Call for Application 2022 Opening soon!
Next Roadshow November 17th
Program Duration 9 months
Data-driven, personalized, high-risk pregnancy care through an app promoting lifestyle changes. Adira health empowers pregnant women diagnosed with high blood pressure, gestational hypertension, and pre-eclampsia to gain awareness of their condition, signs, and symptoms improving birth experience and healthspan. Our health data and wellbeing counseling combined with care coordination enables better pregnancy outcomes for mom and baby.
Beyond Genomix is a clinical stage MedTech developing next generation technologies for ncDNA analysis. With a focus on reproductive health, we have developed the only infertility test, capable of diagnosing every woman including those with an idiopathic condition, from the comfort of their home.
CareMother Baby Beat is a portable, wireless, smartphone based, non-stress test (NST) device with AI capability, that can be used by mothers for self-monitoring of fetal health at home, with results shared with their doctor online for advice.
Egal’s Pads on a Roll help women manage their periods safely, privately, hygienically and with dignity. Pads on a Roll look like toilet paper, are individually wrapped, and are installed next to toilet paper so the products are available when and where they are needed. Typically period pads or tampons, if they are even stocked, are located in separate vending machines by the sink -- not where you want to find them, and often too late to help.
Egal means equal…all bodily functions should be treated equally.
Hale is a platform providing women with chronic pelvic pain with personalized mental health, to improve their quality of life.
Research confirms that mental health is metabolic health. HEALTHY-LONGER has developed and validated the first neuro-metabolic assessment and neuro-nutritional treatment addressing the root cause of mental health vulnerability and disorders – neuro-nutrient deficiencies. The technology is intended to be the first metabolic neuro-biomarker based diagnostic tool in mental health.
Hyivy Health creates a data-driven pelvic rehabilitation system for the 1 in 3 women worldwide who will experience a pelvic health complication in their lifetime. Our system provides the first quantifiable data set on the pelvic floor by using our Floora device to conduct 3 different therapies, which are tracked using multiple biosensors.
Intignus Biotech is developing simple and accessible solutions in the area of maternal and child health care. We aim to better clinical, operational, and economic outcomes by using point-of-care tests that allow on-the-spot decision-making for clinicians. Our first product addresses the unmet need for early screening of preeclampsia. This pregnancy-related disorder can strike quickly, potentially causing severe and immediate complications unless the pregnancy is induced. We have developed an affordable and easy-to-use screening test for all pregnant women which can predict preeclampsia development in the upcoming weeks of gestation.
LumaWomb is a medical device that enables women with impaired endometrium to carry her own child. Using near-infrared, the device improves fertility by creating an adequately thick endometrial lining, thus providing conditions for a fertilized egg to implant. LumaWomb is a non-invasive PBM emanation device healing the endometrial layer to promote blastocystimplantation in the womb.
Malaica is designing a remote pregnancy support program to make pregnancy safe and convenient for African Pregnant women. The program offers a dedicated nurse midwife as a coach, a community of Pregnant women, personalized education, and support accessing all appropriate healthcare. Plus, many health interventions are delivered 100% remotely.
We boost In Vitro Fertilisation success, helping doctors in decision-making by detecting the right timing for embryo transfer. We measure uterine readiness for embryo transfer on the same day of the transfer without interfering with the patient's journey and preserving endometrial tissue integrity.
With our AI-driven technologies we increase chances for people to become parents. We provide greater accuracy in the diagnostic and treatment process, reducing the time and cost associated with fertility treatments and leading to better outcomes for our customers. Our flagship solutions are EMBRYOAID for automatic embryo ranking and FOLLISCAN - a 10-second ai-powered follicular ultrasound monitoring. Founder-led and with most PhDs, we have 50 experienced AI specialists.
Natal Cares is a social enterprise that leverages the power of Mobile Technology, Machine Learning, and Low-Cost Innovation to combat maternal and infant mortality in Nigeria. Primarily focusing on providing mental and emotional healthcare support, medical monitoring, and emergency services to at-risk pregnant women, vulnerable children, and nursing mothers, reaching them in their hometowns and villages, and advocating for better access to healthcare at primary healthcare centers, especially in underserved communities.
LoOoP by Neuraura: Restoring Women’s Reproductive and Metabolic Health with a Wearable Bioelectronic Device. Neuraura is bringing to market the first effective, widely accessible treatment for PCOS as an over-the-counter, affordable device that augments the body's natural processes rather than just masking the symptoms.
NuroKorFemtech is developing new technology that can deploy personalized treatments that meet the needs of each individual and their experience of painful conditions affecting female reproductive health. Our team is bringing together expertise in bioelectronics, data science, and AI/ML to create the world’s first adaptive app-driven technology for menstrual health. We are on a real mission to revolutionize women's healthcare with the smartest therapeutic wearable. Period.
Palpa is a unique product to train breast self-examination in the shower. It is a breast-shaped device that teaches women what an abnormality feels like and how to detect a tumor in their breasts to improve early detection of breast cancer during their shower routine.
Predilife, a french pioneer in predictive medicine, designs and markets MammoRisk, a tool that allows each woman to know her risk of developing breast cancer. MammoRisk integrates the latest scientific knowledge on risk factors (clinical data, imaging, and medical biology, genetic test), and combines proven medical techniques with Artificial Intelligence and Big Data. MammoRisk is the breast cancer risk prediction test chosen for the MyPeBS study, the largest European clinical trial in charge of the individual breast cancer risk assessment platform (55 000 women from 7 countries). MyPeBS's goal is the generalized use of personalized screening with Mammorisk® in Europe (125 million women over 40). The European Union funds this project.
Ru Medical is creating innovative technologies to transform menopausal care. Unpause is our holistic digital platform where menopausal women can log and track their symptoms and treatments to understand their journey better. The platform also connects to novel non-invasive technologies to relieve specific symptoms of menopause. Coolzen, our premier smart wearable, provides relief from hot flashes using the body’s natural cooling mechanism to bring instant relief to the user.
Samphire Neuroscience is a women's health company that builds neurotechnology-based solutions for neglected women's health needs. Its first medical device, the Samphire Hairband, will be available in early 2024 and is a wearable, non-invasive device that can address premenstrual low mood, anxiety, and menstrual pain complaints in women of reproductive age with diagnoses of PMS, PMDD, and dysmenorrhea from a home setting, drastically improving the standard of care and reducing the time to treatment for most women with these conditions
SelfCerve is a self-administered medical device that allows women in low-resource settings to screen for cervical cancer. Our technology eliminates needing an exam bed, stirrups, and even a trained practitioner for a diagnosis. Our mission with SelfCerve is to reach the last mile by normalizing cervical cancer screening globally. With the distribution of the SelfCerve device, we enable low-cost, quality screening with the ultimate goal of increased treatment of precancerous lesions.
WakeUp Pelvic is a digital health start-up that supports women in achieving pelvic physiotherapy goals. We offer a personalized approach to pelvic rehabilitation and empower women to take an active role in their treatment.
Data-driven, personalized, high-risk pregnancy care through an app promoting lifestyle changes. Adira health empowers pregnant women diagnosed with high blood pressure, gestational hypertension, and pre-eclampsia to gain awareness of their condition, signs, and symptoms improving birth experience and healthspan. Our health data and wellbeing counseling combined with care coordination enables better pregnancy outcomes for mom and baby.
CareMother Baby Beat is a portable, wireless, smartphone based, non-stress test (NST) device with AI capability, that can be used by mothers for self-monitoring of fetal health at home, with results shared with their doctor online for advice.
Intignus Biotech is developing simple and accessible solutions in the area of maternal and child health care. We aim to better clinical, operational, and economic outcomes by using point-of-care tests that allow on-the-spot decision-making for clinicians. Our first product addresses the unmet need for early screening of preeclampsia. This pregnancy-related disorder can strike quickly, potentially causing severe and immediate complications unless the pregnancy is induced. We have developed an affordable and easy-to-use screening test for all pregnant women which can predict preeclampsia development in the upcoming weeks of gestation.
Malaica is designing a remote pregnancy support program to make pregnancy safe and convenient for African Pregnant women. The program offers a dedicated nurse midwife as a coach, a community of Pregnant women, personalized education, and support accessing all appropriate healthcare. Plus, many health interventions are delivered 100% remotely.
Hale is a platform providing women with chronic pelvic pain with personalized mental health, to improve their quality of life.
Hyivy Health creates a data-driven pelvic rehabilitation system for the 1 in 3 women worldwide who will experience a pelvic health complication in their lifetime. Our system provides the first quantifiable data set on the pelvic floor by using our Floora device to conduct 3 different therapies, which are tracked using multiple biosensors.
Natal Cares is a social enterprise that leverages the power of Mobile Technology, Machine Learning, and Low-Cost Innovation to combat maternal and infant mortality in Nigeria. Primarily focusing on providing mental and emotional healthcare support, medical monitoring, and emergency services to at-risk pregnant women, vulnerable children, and nursing mothers, reaching them in their hometowns and villages, and advocating for better access to healthcare at primary healthcare centers, especially in underserved communities.
Egal’s Pads on a Roll help women manage their periods safely, privately, hygienically and with dignity. Pads on a Roll look like toilet paper, are individually wrapped, and are installed next to toilet paper so the products are available when and where they are needed. Typically period pads or tampons, if they are even stocked, are located in separate vending machines by the sink -- not where you want to find them, and often too late to help.
Egal means equal…all bodily functions should be treated equally.
Beyond Genomix is a clinical stage MedTech developing next generation technologies for ncDNA analysis. With a focus on reproductive health, we have developed the only infertility test, capable of diagnosing every woman including those with an idiopathic condition, from the comfort of their home.
LumaWomb is a medical device that enables women with impaired endometrium to carry her own child. Using near-infrared, the device improves fertility by creating an adequately thick endometrial lining, thus providing conditions for a fertilized egg to implant. LumaWomb is a non-invasive PBM emanation device healing the endometrial layer to promote blastocystimplantation in the womb.
We boost In Vitro Fertilisation success, helping doctors in decision-making by detecting the right timing for embryo transfer. We measure uterine readiness for embryo transfer on the same day of the transfer without interfering with the patient's journey and preserving endometrial tissue integrity.
With our AI-driven technologies we increase chances for people to become parents. We provide greater accuracy in the diagnostic and treatment process, reducing the time and cost associated with fertility treatments and leading to better outcomes for our customers. Our flagship solutions are EMBRYOAID for automatic embryo ranking and FOLLISCAN - a 10-second ai-powered follicular ultrasound monitoring. Founder-led and with most PhDs, we have 50 experienced AI specialists.
LoOoP by Neuraura: Restoring Women’s Reproductive and Metabolic Health with a Wearable Bioelectronic Device. Neuraura is bringing to market the first effective, widely accessible treatment for PCOS as an over-the-counter, affordable device that augments the body's natural processes rather than just masking the symptoms.
Ru Medical is creating innovative technologies to transform menopausal care. Unpause is our holistic digital platform where menopausal women can log and track their symptoms and treatments to understand their journey better. The platform also connects to novel non-invasive technologies to relieve specific symptoms of menopause. Coolzen, our premier smart wearable, provides relief from hot flashes using the body’s natural cooling mechanism to bring instant relief to the user.
Research confirms that mental health is metabolic health. HEALTHY-LONGER has developed and validated the first neuro-metabolic assessment and neuro-nutritional treatment addressing the root cause of mental health vulnerability and disorders – neuro-nutrient deficiencies. The technology is intended to be the first metabolic neuro-biomarker based diagnostic tool in mental health.
Palpa is a unique product to train breast self-examination in the shower. It is a breast-shaped device that teaches women what an abnormality feels like and how to detect a tumor in their breasts to improve early detection of breast cancer during their shower routine.
Predilife, a french pioneer in predictive medicine, designs and markets MammoRisk, a tool that allows each woman to know her risk of developing breast cancer. MammoRisk integrates the latest scientific knowledge on risk factors (clinical data, imaging, and medical biology, genetic test), and combines proven medical techniques with Artificial Intelligence and Big Data. MammoRisk is the breast cancer risk prediction test chosen for the MyPeBS study, the largest European clinical trial in charge of the individual breast cancer risk assessment platform (55 000 women from 7 countries). MyPeBS's goal is the generalized use of personalized screening with Mammorisk® in Europe (125 million women over 40). The European Union funds this project.
SelfCerve is a self-administered medical device that allows women in low-resource settings to screen for cervical cancer. Our technology eliminates needing an exam bed, stirrups, and even a trained practitioner for a diagnosis. Our mission with SelfCerve is to reach the last mile by normalizing cervical cancer screening globally. With the distribution of the SelfCerve device, we enable low-cost, quality screening with the ultimate goal of increased treatment of precancerous lesions.
NuroKorFemtech is developing new technology that can deploy personalized treatments that meet the needs of each individual and their experience of painful conditions affecting female reproductive health. Our team is bringing together expertise in bioelectronics, data science, and AI/ML to create the world’s first adaptive app-driven technology for menstrual health. We are on a real mission to revolutionize women's healthcare with the smartest therapeutic wearable. Period.
Samphire Neuroscience is a women's health company that builds neurotechnology-based solutions for neglected women's health needs. Its first medical device, the Samphire Hairband, will be available in early 2024 and is a wearable, non-invasive device that can address premenstrual low mood, anxiety, and menstrual pain complaints in women of reproductive age with diagnoses of PMS, PMDD, and dysmenorrhea from a home setting, drastically improving the standard of care and reducing the time to treatment for most women with these conditions
WakeUp Pelvic is a digital health start-up that supports women in achieving pelvic physiotherapy goals. We offer a personalized approach to pelvic rehabilitation and empower women to take an active role in their treatment.